Pastu Covac vaccine approved for children under 18

TEHRAN – Pastu Covac, developed jointly by the Pasteur Institute of Iran and Cuba's Finlay Vaccine Institute, is the only homegrown vaccine that includes use in children aged under 18.

Cov Pars begins third phase of clinical studies

TEHRAN – “Razi Cov Pars” vaccine entered on Sunday the third phase of the human trial, being administrated to 40,000 people, IRIB reported.

IRCS denies sending coronavirus vaccines to Venezuela

TEHRAN – The Iranian Red Crescent Society (IRCS), has denied sending any shipment of COVID-19 vaccines from Iran to Venezuela.

Spikogen vaccine enters third phase of clinical trial

TEHRAN – The Iranian-Australian coronavirus vaccine Spikogen started the third phase of the clinical trial with the participation of 17,000 people on Saturday.

More 200,000 doses of COVIRAN vaccine delivered

TEHRAN – Some 200,000 doses of COVIRAN BAREKAT vaccine have been recently delivered to the Ministry of Health for public vaccination, Hassan Jalili, the vaccine’s production manager, said on Sunday.

Cov Pars to produce 1m doses of vaccine monthly

TEHRAN – One million doses of “Razi Cov Pars” vaccine will be produced each month as of the sixth calendar month Shahrivar (starting August 23), Mohammad-Hassan Fallah Mehrabadi, deputy head of the Razi Vaccine and Serum Research Institute has announced.

COVIRAN BAREKAT in process to WHO’s registration

TEHRAN – COVIRAN BAREKAT, the first Iranian-made coronavirus vaccine, is in the process to be registered by the World Health Organization, Asghar Abdoli, an expert in the vaccine production project, has stated.

Pastu Covac is world’s only vaccine targeting several mutations: expert

TEHRAN – Pastu Covac coronavirus vaccine, developed jointly by the Pasteur Institute of Iran and Cuba's Finlay Vaccine Institute, is the only vaccine in the world that can fight several mutations simultaneously, Alireza Biglari, head of the Pasteur Institute, has said.

Import of coronavirus vaccine to reach 13m doses

TEHRAN – Twenty shipments of COVID-19 vaccine have so far been imported into the country, and the volume will soon reach 13 million doses.

Foreign students in Iran to get coronavirus vaccine

TEHRAN – Foreign students who are studying at Iranian universities will be vaccinated against the virus along with Iranian students, Afshin Akhoundzadeh, an official at the Organization of Student Affairs has said.

Second Iranian coronavirus vaccine gets emergency use license

TEHRAN - The Pastu Covac vaccine, developed by the Pasteur Institute of Iran, has received an emergency use license, Health Minister Saeed Namaki said on Wednesday.

Cov Pars to monthly produce 1m doses of vaccine

TEHRAN – One million doses of “Razi Cov Pars” vaccine will be produced each month as of September, deputy head of the Razi Vaccine and Serum Research Institute has announced.

COVIRAN vaccine receives public use license

TEHRAN – Homegrown COVIRAN BAREKAT vaccine has received the license for public use, Health Minister Saeed Namaki announced on Monday.

Fakhra vaccine begins second human trial

TEHRAN – The second phase of the Fakhra vaccine’s human trial started on Wednesday by being administrated to 500 volunteers.

COVID-19 inoculation to rollout by homegrown vaccine this week

TEHRAN – Health Minister Saeed Namaki announced that immunization against coronavirus by the domestic vaccine (COVIRAN BAREKAT) will start by the next week, ISNA reported on Monday.

Iran-Cuba vaccine to complete clinical trials by mid-June

TEHRAN – Soberana-02 COVID-19 vaccine jointly developed by Iran and Cuba will complete clinical trials by mid-June by being administered to 24,000 Iranians.

Razi Cov Pars enters second clinical trial phase

TEHRAN – The second Iranian-made coronavirus vaccine, named Razi Cov Pars, started the second phase of the human trial on Friday by being administrated to 500 people.

No COVID-19 vaccine export until domestic need is met

TEHRAN – No homegrown COVID-19 vaccine will be exported until the domestic need is fully met, although several countries have asked for purchasing the COVIRAN BAREKAT vaccine, Mohammad Mokhber, the head of the Headquarters for Executing the Order of the Imam, has said.

Iran receives second shipment of COVAX vaccines

TEHRAN – Iran has received the second batch of the COVID-19 vaccine from the COVAX facility on Sunday.

Iran to likely receive 10m doses of COVID-19 vaccine by early June

TEHRAN – Iran will receive about 10 million doses of COVID-19 vaccine by early June if the supply process goes on according to schedule, Sadeq Tabrizi, a health ministry official, said on Monday.

Fakhra vaccine completes first phase of human trial

TEHRAN – The first phase of the Fakhra vaccine’s human trial has been completed successfully and the second phase will start after the final analysis.

Iranian-made “Sputnik V” to be available by mid-June

TEHRAN – Iran will release jointly-produced Russian “Sputnik V” vaccine by the end of spring (June 21), Kianoush Jahanpour, head of the Information Center of the Ministry of Health, has announced.

COVIRAN vaccine starts third phase of human trial

TEHRAN – COVIRAN BAREKAT, the first coronavirus vaccine made by Iranian researchers, started the third phase of the human trial, Mostafa Qanei, secretary of the biotechnology development office of the Vice Presidency for Science and Technology, announced.

Iran finalizes deal for 60 million "Sputnik V" vaccines

TEHRAN – Iran has finalized a deal with Russia to purchase 60 million doses of Sputnik V vaccine, Iranian Ambassador to Moscow Kazem Jalali said on Thursday.

Iran unveils, tests new COVID-19 vaccine

Fakhra vaccine is named after martyred nuclear scientist Mohsen Fakhrizadeh

TEHRAN – Fakhra vaccine, named after martyred nuclear scientist Mohsen Fakhrizadeh, was unveiled and started the clinical trial on Tuesday, IRNA reported.

Second Iranian COVID-19 vaccine enters clinical trial

TEHRAN – Iran started the human trial of its second coronavirus vaccine, Razi Cov Pars, by injecting it into two volunteers during a ceremony on Sunday.

Iranian-made coronavirus vaccine 90% immunogenic: study

TEHRAN – Tests performed on volunteers who received the Iranian-made COVID-19 vaccine showed that the immunogenicity of “COVIRAN BAREKAT” is about 90 percent.

No vaccine as effective as Iranian vaccine against UK variant

TEHRAN –Test results have shown that the Iranian-made coronavirus vaccine is highly effective against the British mutated coronavirus virus and no other vaccine in the world has been so effective, Minoo Mohrez, member of the National Headquarters for Coronavirus Control, has stated.

Iran to start mass vaccination against coronavirus this week

TEHRAN – Mass vaccination against COVID-19 will begin this week, with the priority given to medical staff, the elderly, and people with underlying diseases, President Hassan Rouhani announced on Saturday.